Living with Uncertainty

Thanks to funding secured from the National Lottery Community Fund, we have launched our Living with Uncertainty programme group sessions.

What is the aim of the Living with Uncertainty programme?

The aim of this patient programme is to assist people living with cancer to develop skills to live a full and meaningful life alongside their condition using Acceptance and Commitment Therapy (ACT).   

Who is the Living with Uncertainty programme for?

This programme is for those experiencing a level of distress in relation to the uncertainty associated with their cancer diagnosis that impacts their ability to live life in a way that is meaningful and satisfying to them. An example of uncertainty caused by cancer diagnosis may include (but not limited to);

Those living with cancer that is incurable.
Those diagnosed with a rare cancer type.  
Those with cancer of unknown primary origin.
Those participating in clinical trials. 
Those who have had their treatment pathway significantly disrupted by the Covid-19 pandemic.

How do the group sessions work?

The Living with Uncertainty group programme consists of 6 group sessions split across 6 consecutive weeks. Groups are delivered by a psychologist and a facilitator. Each session lasts for 2 hours and consist of a maximum of 10 participants. During these sessions, participants learn skills to manage fear and anxiety so that they can get back to living the life that they want for themselves. Due to current pandemic restrictions, these groups are offered virtually via Zoom currently and have also been offered face to face prior to this.

What will I learn during these sessions?

An Acceptance Commitment Therapy approach is used to help participants live alongside difficult thoughts and feelings associated with their cancer diagnosis and the uncertainty this has caused for them. The 6-week programme explores participant values and goals while engaging with a range of techniques to help move forward in a way that makes life meaningful for each individual.